Emerging Concepts for the Treatment of Biofilm-Associated Bone and Joint Infections with IV Fosfomycin: A Literature Review
Due to the involvement of biofilms in the pathogenesis of bone and joint infections (BJI), the treatment of these infections is often challenging, especially when multidrug- or extensively drug-resistant (MDR/XDR) pathogens are involved. Intravenous fosfomycin (FOS) is a phosphoenolpyruvate analogue...
| Published in: | Microorganisms |
|---|---|
| Main Authors: | Sara Tedeschi, Efthymia Giannitsioti, Christian Mayer |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/13/5/963 |
Similar Items
Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic <i>Escherichia coli</i> Clinical Isolates
by: Haziel Eleazar Dzib-Baak, et al.
Published: (2022-09-01)
by: Haziel Eleazar Dzib-Baak, et al.
Published: (2022-09-01)
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study
by: Klaus-Friedrich Bodmann, et al.
Published: (2025-03-01)
by: Klaus-Friedrich Bodmann, et al.
Published: (2025-03-01)
In Vitro Susceptibility of Multi-Drug Resistant <i>Klebsiella</i><i>pneumoniae</i> Strains Causing Nosocomial Infections to Fosfomycin. A Comparison of Determination Methods
by: Beata Mączyńska, et al.
Published: (2021-04-01)
by: Beata Mączyńska, et al.
Published: (2021-04-01)
In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Aghata Cardoso da Silva Ribeiro, et al.
Published: (2023-01-01)
by: Aghata Cardoso da Silva Ribeiro, et al.
Published: (2023-01-01)
Evolution of Antimicrobial Resistance in <i>Klebsiella pneumoniae</i> over 3 Years (2019–2021) in a Tertiary Hospital in Bucharest, Romania
by: Alexandra Cireșă, et al.
Published: (2024-05-01)
by: Alexandra Cireșă, et al.
Published: (2024-05-01)
Fosfomycin, Applying Known Methods and Remedies to A New Era
by: Viviana Albán M., et al.
Published: (2020-08-01)
by: Viviana Albán M., et al.
Published: (2020-08-01)
Molecular Investigation of <i>Klebsiella pneumoniae</i> from Clinical Companion Animals in Beijing, China, 2017–2019
by: Zhenbiao Zhang, et al.
Published: (2021-02-01)
by: Zhenbiao Zhang, et al.
Published: (2021-02-01)
Intravenous Fosfomycin for Systemic Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections
by: Giuseppe Pipitone, et al.
Published: (2023-11-01)
by: Giuseppe Pipitone, et al.
Published: (2023-11-01)
High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and <i>Acinetobacter baumannii</i>
by: Massimiliano De Angelis, et al.
Published: (2022-02-01)
by: Massimiliano De Angelis, et al.
Published: (2022-02-01)
Synergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Venera Costantino, et al.
Published: (2024-06-01)
by: Venera Costantino, et al.
Published: (2024-06-01)
Physicochemical and Antimicrobial Properties of Thermosensitive Chitosan Hydrogel Loaded with Fosfomycin
by: Luke J. Tucker, et al.
Published: (2021-03-01)
by: Luke J. Tucker, et al.
Published: (2021-03-01)
Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01)
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01)
Gut Microbiome and Intestinal Colonization with Multidrug-Resistant Strains of Enterobacterales: An Interplay Between Microbial Communities
by: Béla Kocsis, et al.
Published: (2025-09-01)
by: Béla Kocsis, et al.
Published: (2025-09-01)
Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>
by: Anthony Sophonsri, et al.
Published: (2024-05-01)
by: Anthony Sophonsri, et al.
Published: (2024-05-01)
Urinary Tract Infections with Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in a Urology Clinic—A Case-Control Study
by: Viorel Dragos Radu, et al.
Published: (2024-06-01)
by: Viorel Dragos Radu, et al.
Published: (2024-06-01)
Mutations of the Transporter Proteins GlpT and UhpT Confer Fosfomycin Resistance in Staphylococcus aureus
by: Su Xu, et al.
Published: (2017-05-01)
by: Su Xu, et al.
Published: (2017-05-01)
In Vitro Antibiofilm Activity of Fosfomycin Alone and in Combination with Other Antibiotics against Multidrug-Resistant and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i>
by: Mia Slade-Vitković, et al.
Published: (2024-06-01)
by: Mia Slade-Vitković, et al.
Published: (2024-06-01)
Molecular Characteristics and Quantitative Proteomic Analysis of <i>Klebsiella pneumoniae</i> Strains with Carbapenem and Colistin Resistance
by: Ling Hao, et al.
Published: (2022-09-01)
by: Ling Hao, et al.
Published: (2022-09-01)
Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?
by: Song Oh, et al.
Published: (2021-05-01)
by: Song Oh, et al.
Published: (2021-05-01)
Ertapenem+meropenem including double carbapenem therapy (EMDCT) versus meropenem+imipenem including double carbapenem therapy (MIDCT) in the therapy of carbapenem-resistant Klebsiella pneumoniae infections (CRKPI): A retrospective matched cohort stud
by: Merve Mert Vahabi, et al.
Published: (2024-12-01)
by: Merve Mert Vahabi, et al.
Published: (2024-12-01)
Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates in a Hollow-Fibre Infection Model
by: Sazlyna Mohd Sazlly Lim, et al.
Published: (2022-11-01)
by: Sazlyna Mohd Sazlly Lim, et al.
Published: (2022-11-01)
VT-1161—A Tetrazole for Management of Mono- and Dual-Species Biofilms
by: Angela Maione, et al.
Published: (2023-01-01)
by: Angela Maione, et al.
Published: (2023-01-01)
A Decade-Long Review of the Virulence, Resistance, and Epidemiological Risks of <i>Klebsiella pneumoniae</i> in ICUs
by: Tao-An Chen, et al.
Published: (2024-12-01)
by: Tao-An Chen, et al.
Published: (2024-12-01)
Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
by: Antonio Sorlozano-Puerto, et al.
Published: (2020-08-01)
by: Antonio Sorlozano-Puerto, et al.
Published: (2020-08-01)
Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases
by: Milo Gatti, et al.
Published: (2022-01-01)
by: Milo Gatti, et al.
Published: (2022-01-01)
Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
by: Vittoria Mattioni Marchetti, et al.
Published: (2023-07-01)
by: Vittoria Mattioni Marchetti, et al.
Published: (2023-07-01)
The Predominance of <i>Klebsiella aerogenes</i> among Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections in Japan
by: Kosuke Kamio, et al.
Published: (2022-06-01)
by: Kosuke Kamio, et al.
Published: (2022-06-01)
Disinfection Strategies for Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in a Healthcare Facility
by: Lijia Ni, et al.
Published: (2022-05-01)
by: Lijia Ni, et al.
Published: (2022-05-01)
Genetic Characterization of Carbapenem-Resistant <i>Klebsiella</i> spp. from Municipal and Slaughterhouse Wastewater
by: Mykhailo Savin, et al.
Published: (2022-03-01)
by: Mykhailo Savin, et al.
Published: (2022-03-01)
Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant <i>Klebsiella Pneumoniae</i>: Exploring A Colistin Sparing Protocol
by: Manawr AL-Quraini, et al.
Published: (2022-01-01)
by: Manawr AL-Quraini, et al.
Published: (2022-01-01)
<i>Klebsiella pneumonia</i> in Sudan: Multidrug Resistance, Polyclonal Dissemination, and Virulence
by: Einas A. Osman, et al.
Published: (2023-01-01)
by: Einas A. Osman, et al.
Published: (2023-01-01)
Resistance to Ceftazidime/Avibactam in <i>Klebsiella pneumoniae</i> KPC-Producing Isolates: A Real-Life Observational Study
by: Laura Campogiani, et al.
Published: (2023-04-01)
by: Laura Campogiani, et al.
Published: (2023-04-01)
Assessing the Influence of Urine pH on the Efficacy of Ciprofloxacin and Fosfomycin in Immunocompetent and Immunocompromised Murine Models of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Infection in the Lower Urinary Tract
by: Soraya Herrera-Espejo, et al.
Published: (2024-09-01)
by: Soraya Herrera-Espejo, et al.
Published: (2024-09-01)
Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales
by: Joaquin Burgos, et al.
Published: (2023-10-01)
by: Joaquin Burgos, et al.
Published: (2023-10-01)
Antibiotic Tolerance of <i>Staphylococcus aureus</i> Biofilm in Periprosthetic Joint Infections and Antibiofilm Strategies
by: Fabien Lamret, et al.
Published: (2020-08-01)
by: Fabien Lamret, et al.
Published: (2020-08-01)
The Emergence of <i>Klebsiella pneumoniae</i> with Reduced Susceptibility against Third Generation Cephalosporins and Carbapenems in Lagos Hospitals, Nigeria
by: Kabiru O. Akinyemi, et al.
Published: (2021-02-01)
by: Kabiru O. Akinyemi, et al.
Published: (2021-02-01)
Molecular Characterization of Carbapenem and Colistin Resistance in <i>Klebsiella pneumoniae</i> Isolates Obtained from Clinical Samples at a University Hospital Center in Algeria
by: Riyane Rihane, et al.
Published: (2024-09-01)
by: Riyane Rihane, et al.
Published: (2024-09-01)
Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
by: Ruan Z, et al.
Published: (2020-08-01)
by: Ruan Z, et al.
Published: (2020-08-01)
Biofilm Eradication by Symmetrical Selenoesters for Food-Borne Pathogens
by: Márta Nové, et al.
Published: (2020-04-01)
by: Márta Nové, et al.
Published: (2020-04-01)
Fosfomycin susceptibility in multidrug resistant uropathogens: A retrospective study in the era of antimicrobial resistance
by: Jasleen Kaur, et al.
Published: (2025-04-01)
by: Jasleen Kaur, et al.
Published: (2025-04-01)
Similar Items
-
Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic <i>Escherichia coli</i> Clinical Isolates
by: Haziel Eleazar Dzib-Baak, et al.
Published: (2022-09-01) -
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study
by: Klaus-Friedrich Bodmann, et al.
Published: (2025-03-01) -
In Vitro Susceptibility of Multi-Drug Resistant <i>Klebsiella</i><i>pneumoniae</i> Strains Causing Nosocomial Infections to Fosfomycin. A Comparison of Determination Methods
by: Beata Mączyńska, et al.
Published: (2021-04-01) -
In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Aghata Cardoso da Silva Ribeiro, et al.
Published: (2023-01-01) -
Evolution of Antimicrobial Resistance in <i>Klebsiella pneumoniae</i> over 3 Years (2019–2021) in a Tertiary Hospital in Bucharest, Romania
by: Alexandra Cireșă, et al.
Published: (2024-05-01)
